Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -9,240 | -8,278 | -26,730 | N/A |
| Depreciation Amortization | 417 | 313 | 220 | N/A |
| Accounts receivable | -988 | 478 | N/A | N/A |
| Other Working Capital | -305 | 332 | 230 | N/A |
| Other Operating Activity | 988 | -406 | 19,550 | 0 |
| Operating Cash Flow | $-9,129 | $-7,561 | $-6,730 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -813 | -135 | -110 | N/A |
| Net Acquisitions | N/A | -72 | -2,200 | N/A |
| Purchase Sale Intangibles | -283 | -283 | N/A | N/A |
| Other Investing Activity | -283 | -283 | -260 | 0 |
| Investing Cash Flow | $-1,096 | $-490 | $-2,570 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 27,440 | 8,225 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 180 | 0 |
| Financing Cash Flow | $27,440 | $8,225 | $180 | $N/A |
| Beginning Cash Position | 8,683 | 8,510 | 17,630 | N/A |
| End Cash Position | 25,899 | 8,683 | 8,510 | N/A |
| Net Cash Flow | $17,216 | $173 | $-9,120 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -9,129 | -7,561 | -6,730 | N/A |
| Capital Expenditure | -813 | -135 | N/A | N/A |
| Free Cash Flow | -9,942 | -7,697 | -6,730 | 0 |